Jun 7, 2019

Faculty presentations from an independent satellite symposium during the Society of Gynecologic Oncology’s 2019 Annual Meeting on Women’s Cancer. Featuring perspectives from Dr Michael J Birrer, David M O’Malley, Matthew A Powell and Shannon N Westin:

• Biologic Rationale for and Current Research Database with Immune Checkpoint Inhibition in Gynecologic Cancers — Dr Powell (00:00)
• Targeting Folate Receptor Alpha (FRα) in Patients with Gynecologic Cancers — Dr Birrer (7:54)
• Other Novel Agents and Strategies Under Investigation for Cervical Cancer, Endometrial Cancer and Ovarian Cancer — Dr O’Malley (17:27)
• Ongoing Trials Examining the Role of Anti-PD-1/PD-L1 Antibodies in Combination with Chemotherapy, Targeted Agents or Other Immunotherapeutics — Dr Westin (27:50)

 Select publications